Patents by Inventor William Mather Almon Carscallen

William Mather Almon Carscallen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Engineered Microorganisms for Producing Substituted Tryptamines
    Publication number: 20230416794
    Abstract: Provided herein are microorganisms for producing substituted tryptamines and cell cultures thereof, the microorganisms comprising at least one exogenous nucleic acid molecule that encodes at least one substituted tryptamine biosynthetic pathway enzyme.
    Type: Application
    Filed: November 15, 2021
    Publication date: December 28, 2023
    Inventors: Fatima Awwad, William Mather Almon Carscallen, Elisa Ines Fantino
  • Engineered microorganism for the production of cannabinoid biosynthetic pathway products
    Patent number: 11746351
    Abstract: A genetically engineered microorganism for the production of a cannabinoid biosynthetic pathway product is described. The genetically engineered microorganism comprises at least one nucleic acid molecule encoding at least one cannabinoid biosynthetic pathway enzyme. The disclosure also relates to methods for producing a cannabinoid biosynthetic pathway product using a genetically engineered microorganism.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: September 5, 2023
    Assignee: Algae-C Inc.
    Inventors: William Mather Almon Carscallen, Isabel Desgagné-Penix, Jean-Francois Lemay
  • ENGINEERED MICROORGANISM FOR THE PRODUCTION OF CANNABINOID BIOSYNTHETIC PATHWAY PRODUCTS
    Publication number: 20210189402
    Abstract: A genetically engineered microorganism for the production of a cannabinoid biosynthetic pathway product is described. The genetically engineered microorganism comprises at least one nucleic acid molecule encoding at least one cannabinoid biosynthetic path-way enzyme. The disclosure also relates to methods for producing a cannabinoid biosynthetic pathway product using a genetically engineered microorganism.
    Type: Application
    Filed: April 29, 2019
    Publication date: June 24, 2021
    Inventors: William Mather Almon Carscallen, Isabel Desgagné-Penix, Jean-Francois LEMAY